Day: April 29, 2022

Not for distribution to U.S. news wire services or dissemination in the United States. Vancouver, British Columbia, April 29, 2022 (GLOBE NEWSWIRE) — St. James Gold Corp. (the “Company”) (TSXV: LORD) (OTCQB: LRDJF) (FSE: BVU3) is pleased to announce that, effective immediately, the Company has appointed Dr. Tsun Law to its Board of Directors. Dr. Tsun Law MD, MBA is a practicing Orthopedic Physician in South Florida, USA specializing in hip and knee osteoarthritis who is actively engaged in clinical research with a special focus on robotic and sensor technologies, medical innovation, and healthcare investments. Dr. Law has been published in numerous highly regarded peer reviewed medical journals and his research has been accepted for presentation at both national and international orthopedic surgery conferences. Dr. Law is working...

Toronto, ON, April 29, 2022 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company“) (TSX-V: CCB) (OTC: BRUZF) (Frankfurt: U7N1) is pleased to announce the appointment of Remantra Sheopaul as Chief Financial Officer of the Company, replacing Olga Nikitovic, effective immediately. The Company thanks Ms. Nikitovic for her tenure as Chief Financial Officer and Chief Executive Officer through December 2021 and for continuing in a consulting capacity, on accounting and financial matters, through April 2022. Mr. Sheopaul presently works with Marrelli Support Services which provides chief financial officer, accounting, regulatory, compliance and management advisory services to numerous issuers on the TSX, TSX Venture Exchange and other Canadian and U.S. exchanges. Mr. Sheopaul has a focus on building strong relationships with...

ORGOVYX® is the first and only oral androgen deprivation therapy for advanced hormone-sensitive prostate cancer in Europe Myovant expects to secure European commercialization partner ahead of anticipated launchesBASEL, Switzerland, April 29, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) today announced that the European Commission (EC) has approved the marketing authorisation application for ORGOVYX® (relugolix, 120 mg) for the treatment of adult patients with advanced hormone-sensitive prostate cancer. The approval is applicable to all 27 European Union member states plus Iceland, Norway, and Liechtenstein. “Now for the first time, patients in Europe have the ability to rapidly reduce testosterone without hormonal flare in a convenient oral form,” said Juan Camilo Arjona Ferreira, Chief Medical Officer of Myovant Sciences,...

CARLSBAD, Calif, April 29, 2022 (GLOBE NEWSWIRE) — NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICESCompany reports strong revenue growth of 22% in Q4 and expects sequential increase in revenues for Q1 2022 – Management to host conference call on Monday, May 2, 2022 at 11:00 AM ET –Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for the fourth quarter and fiscal year ended December 31, 2021. All figures are in U.S. dollars. Financial and Business Highlights21% Annual Sales Growth – The Company has experienced quarter over quarter sales growth each quarter in 2021 from $2.3 million in Q1 to approximately $3.0...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, April 29, 2022 (GLOBE NEWSWIRE) — AM Resources Corporation (“AM” or the “Corporation”) (TSXV: AMR) (Frankfurt: 76A) is pleased to announce the closing of a second tranche of its previously announced non-brokered private placement (the “Offering”). Pursuant to the Offering, the Corporation raised aggregate gross proceeds of $446,000, consisting of the issuance of 8,920,000 units of the Corporation (each, a “Unit”) at a price of $0.05 per Unit. Each Unit is comprised of one common share of the Corporation and one half of one warrant. Each full warrant entitles the holder to acquire one common share of the Corporation at a price of $0.075 for a period of 24 months from the date of issuance. In connection with the...

The Jøtul Group (representing Jøtul AS together with its subsidiaries) is one of the three largest suppliers of fireplaces in Europe and a significant player in North America. The company, with a history dating back to 1853 through its legacy as one of Norway’s oldest companies, distributes stand-alone stoves, inserts, frames, and accessories for fireplaces. The Group’s main brands are Jøtul, Scan and Ravelli. The Jøtul fireplaces are manufactured from cast iron and appear timeless and robust, with Norwegian origins. The Scan fireplaces are manufactured from plated steel and are characterized by modern Danish design, while the Ravelli pellets stoves are characterized by Italian design and technology. The head office is based in Norway. Manufacturing takes place through own production in Norway, Poland, France, and the USA, in addition...

Nanjing, China, April 29, 2022 (GLOBE NEWSWIRE) —  Ostin Technology Group Co., Ltd. (the “Company”) (NASDAQ: OST), a supplier of display modules and polarizers in China, today announced the closing of its initial public offering (the “Offering”) of 3,881,250 ordinary shares, including 506,250 ordinary shares comprising the underwriters’ over-allotment option which was exercised in full, at a public offering price of $4.00 per ordinary share, for aggregate gross proceeds of $15,525,000 before deducting underwriting discounts and commissions and offering expenses. The Offering closed on April 29, 2022 and the ordinary shares began trading on April 27, 2022 on The Nasdaq Capital Market under the ticker symbol “OST.”  Prime Number Capital LLC acted as lead book-running manager for the offering. Shengang Securities Company...

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company”) (TSXV: HMLO) announces an extension of the binding term sheet with a wholly owned subsidiary of Barrick Gold Corporation (see news release dated April 4, 2022) that originally estimated that the parties would sign a definitive agreement (the “Definitive Agreement”) by April 30, 2022. Both parties continue to work through the due diligence process and are working to finalize the Definitive Agreement in May 2022. About Hemlo Explorers Inc. Hemlo Explorers is a Canadian-based mineral exploration company with a portfolio of properties in Ontario and Nunavut. We are focused on generating shareholder value through the advancement of our main Hemlo area, including the Pic, North Limb and Hemlo West Projects. For more information please contact: Brian Howlett,...